Predictive modeling, the basis for AI technology (e.g., taking young age, long menstrual cycles, polycystic ovary syndrome (PCOS), anti-Müllerian hormone (AMH), and antral follicle count (AFC) into account) has already been shown to reduce cycle cancellation and patient hospitalization for ovarian hyperstimulation syndrome (OHSS), achieving a significant reduction in costs [17]. The gene discussed is AMH; the disease is ovarian hyperstimulation syndrome.